Pricing Log in Create free account

FibroBiologics Inc. (FBLG) vs Lexaria Bioscience Corp. (LEXX)

FibroBiologics Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. FibroBiologics Inc. and Lexaria Bioscience Corp. are of similar size ($6.7M and $6.3M). Across the 9 metrics below, Lexaria Bioscience Corp. leads on 8 and FibroBiologics Inc. on 1.

Valuation

Metric FBLG LEXX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 8.91 9.71
P/B 1.29 1.11 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.36 9.21
Earnings yield (546.32%) (174.57%) (33.15%)
Free cash flow yield (252.58%) (155.80%) (25.50%)

Profitability

Metric FBLG LEXX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (660.08%) (162.60%) (56.36%)
Return on assets (166.14%) (134.20%) (48.04%)
Return on invested capital (932.71%) (662.56%) 0.00%

Growth

Metric FBLG LEXX Biotechnology median
Revenue growth (TTM) — 9.08% 6.02%
EPS growth (last fiscal year) (23.53%) (40.43%) 30.26%
Revenue growth, 5-year CAGR — 17.53% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric FBLG LEXX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.64 10.60 4.72
Net debt to EBITDA 0.31 0.17 0.96

Dividend

Metric FBLG LEXX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FBLG LEXX Biotechnology median
Market cap 6.66m 6.30m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack